Single-dose treatment of athlete’s foot with terbinafine: report from a Dermatology Expert Panel

References

• Brennan B, Leyden JJ. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J. Am. Acad. Dermatol.36, S3–S8 (1997).
   Web of Science ®Google Scholar
• Meinhof W, Girardi RM, Stracke A. Patient non-compliance in dermatomycosis: results of a survey among dermatologists, general practitioners and patients. Dermatologica169(Suppl. 1), 57–66 (1984).
   PubMedGoogle Scholar
• Hart R, Bell-Syer SE, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. Br. Med. J.319, 79–82 (1999).
   PubMed Web of Science ®Google Scholar
• Petranyi G, Ryder NS, Stutz A. Allylamine derivatives: a new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science224, 1239–1241 (1984).
   PubMed Web of Science ®Google Scholar
• Lee CK, Uchida T, Kitagawa K, Yagi A, Kim NS, Goto S. Effect of hydrophobic and lipophilic vehicles on skin penetration of tegafur, alclofenac and ibuprofen with or without permeation enhancers. Biol. Pharm. Bull.16, 1264–1269 (1993).
   PubMed Web of Science ®Google Scholar
• Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, Santi P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behaviour. J. Control. Release88, 277–285 (2003).
   PubMed Web of Science ®Google Scholar
• Stokes RP, Diffey BL. The water resistance of sunscreen and day-care products. Br. J. Dermatol.140, 259–263 (1999).
   PubMed Web of Science ®Google Scholar
• Alberti I, Kalia YN, Naik A et al. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J. Control. Release71, 319–327 (2001).
   PubMed Web of Science ®Google Scholar
• Alberti I, Kalia YN, Naik A et al. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int. J. Pharmacol.219, 11–19 (2001).
   Google Scholar
• Rodriguez G. Athlete’s foot: what a patient thinks. Usage and attitudes. Consumer research of 900 respondents in the UK, France and Germany. Novartis Consumer Research. Presented at Expert Panel Conference. London, UK, 14 October 2005.
   Google Scholar
• Bergstresser PR, Elewski B, Hanifin J et al. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens. J. Am. Acad. Dermatol.28, 648–651 (1993).
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Korting HC, Viguie-Vallant C, Larnier C, Savaluny E. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete’s foot): a randomised, double-blind, placebo-controlled study. J. Eur. Acad. Dermatol. Venereol.20, 1307–1313 (2006).
   PubMed Web of Science ®Google Scholar
• Hay R, Roberts SOB, Mackenzie DWR. Mycology. In: Rook, Wilkinson, Ebling Textbook of Dermatology (5th Edition). Campion RH, Burton JL, Ebling FJG (Eds). Blackwell Science Publishing, Oxford, UK, 115–146 (1992).
   Google Scholar
• Hall JC. Dermatologic mycology. In: Sauer’s Manual of Skin Disease. Lippincott Williams & Wilkins, Washington DC, USA, 200–201 (2000).
   Google Scholar
• Fitzpatrick RE, Newcomer VD. Skin diseases. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD (Eds). Saunders, PA, USA, 837–838 (1987).
   Google Scholar
• Reeves JRT, Malbach H. Clinical Dermatology Illustrated (2nd Edition). Maclennan & Petty, Sydney, Australia (1990).
   Google Scholar
• Lehenkari E. Silvennoinen-Kassinen S. Dermatophytes in northern Finland in 1982–90. Mycoses38, 411–414 (1995).
   PubMed Web of Science ®Google Scholar
• Elewski BE, Jones T, Zaias N. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis. Cutis58, 305–307 (1996).
   PubMed Web of Science ®Google Scholar
• Seebacher C, Blaschke-Hellmessen R. Übersicht der mykosen. In: Für die Medizinische Praxis ’Mykosen’. Seebacher C, Blaschke-Hellmessen R (Eds). Gustav Fischer Verlag, Jena, Germany, 50–51 (1990).
   Google Scholar
• Auger P, Marquis G, Joly J, Attye A. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete’s foot. Mycoses36, 35–41 (1993).
   PubMed Web of Science ®Google Scholar
• Broberg A, Faergemann J. Scaly lesions on the feet in children – tinea or eczema? Acta Paediatr. Scand.79, 349–351 (1990).
   PubMed Web of Science ®Google Scholar
• Becerril-Chihu G, Bazan-Mora E, Lopez-Martinez R, Sosa-de-Martinez C, Ruiz-Maldonado R. How often are dermatophytes present in apparently normal versus scaly feet of children? Pediatr. Dermatol.16, 87–89 (1999).
   PubMed Web of Science ®Google Scholar
• Zaror L, Aliaga X. Dermatophytes in healthy Chilians. Mycoses33, 95–98 (1990).
   PubMed Web of Science ®Google Scholar
• Zaias N, Rebell G. Chronic dermatophytosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol.35, S17–S20 (1996).
   Google Scholar
• Maruyama R, Katoh T, Nishioka K. Demonstration of dermatophyte dissemination from the infected soles using the foot-press method. Mycoses41, 145–151 (1998).
   PubMed Web of Science ®Google Scholar
• Roseeuw D. Achilles foot screening project: preliminary results of patients screened by dermatologists. J. Eur. Acad. Dermatol. Venereol.12(Suppl. 1), S6–S9 (1999).
   Google Scholar
• Aste N, Pau M, Aste N, Biggio P. Tinea pedis in Cagliari, Italy, between 1996 and 2000. Mycoses46, 38–41 (2003).
   PubMed Web of Science ®Google Scholar
• Leyden JJ. Progression of interdigital infections from simplex to complex. J. Am. Acad. Dermatol.28, S7–S11 (1993).
   Web of Science ®Google Scholar
• Leyden JJ. Pathophysiology and treatment of tinea pedis. J. Am. Acad. Dermatol.31, S31–S33 (1994).
   PubMed Web of Science ®Google Scholar